IL-1β and IL-6 levels are elevated in the Late-Life Depression (LLD) group compared to healthy controls, with statistically significant differences. The TNF-α level is also higher in the LLD group, but the difference is not statistically significant at the given alpha level. Here, IL1B is linked to depressive symptom measurement.